Diabetic Retinopathy (DR) Research & Clinical Trials

Share:

Sponsor – Regeneron (Recruiting/Open To Enrollment)

Study: PANORAMA
A PHASE 3, DOUBLE-MASKED, RANDOMIZED STUDY OF THE EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT INJECTION IN PATIENTS WITH MODERATELY SEVERE TO SEVERE NONPROLIFERATIVE DIABETIC RETINOPATHY
https://clinicaltrials.gov/ct2/show/NCT02718326?term=PANORAMA&rank=3​

Previous Diabetic Retinopathy (DR) Study:

Sub-Investigator, 2007 - 2009
Protocol FVF4296s: An Open-Label Study to Determine the Dynamics of Regression of Neovascularization in Proliferative Diabetic Retinopathy Following Treatment with Intravitreal Ranibizumab.